Magnetic Resonance Spectroscopy (MRS) Validation Study in Individuals With Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00940537 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2018-06-15
Summary
The purpose of this study is to see how effective the investigators' optimized magnetic resonance spectroscopy (MRS) sequence in quantifying hepatic triglyceride content (HTGC) to enhance MRS as a diagnostic tool in non-alcohol fatty liver disease (NAFLD).
Conditions
Sponsors & Collaborators
-
Washington University School of Medicine
lead OTHER
Principal Investigators
-
Samuel Klein, M.D. · Washinton University in St. Louis
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- United States
Study Locations
More Related Trials
-
De Novo Lipogenesis in Severity of NAFLD
NCT03683589 ·Status: COMPLETED
-
The Tailgate Study: A Pilot Study Measuring the Impact of Acute Alcohol Intake on Intrahepatic Lipid
NCT02141880 ·Status: COMPLETED
-
Physiologic Plasticity of Intramyocardial Lipid Storage
NCT01921075 ·Status: COMPLETED
-
The Liver Health Study for Patients with NAFLD
NCT03151798 ·Status: COMPLETED ·Phase: NA
-
Effects of Intermittent Fasting on Fatty Liver Disease
NCT04795973 ·Status: COMPLETED ·Phase: NA
-
Fatty Liver Response of Cardio-metabolic Risk Factors to Laser Acupuncture Versus Cupping
NCT04971434 ·Status: UNKNOWN ·Phase: NA
-
Changes in Intrahepatic Lipids With Exercise
NCT02181270 ·Status: COMPLETED ·Phase: NA
-
Liver Health and Metabolic Function in People With Obesity
NCT03701828 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
NCT05738707 ·Status: NOT_YET_RECRUITING
-
Measuring Fatty Liver With Ultrasound and MRS in Children With Overweight or Obesity
NCT03787108 ·Status: UNKNOWN
-
Fatty Liver Disease Collaborative Research in China
NCT02391168 ·Status: UNKNOWN
-
Intermittent Fasting in Nonalcoholic Fatty Liver Disease
NCT04355910 ·Status: UNKNOWN ·Phase: NA
-
Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver
NCT05623930 ·Status: UNKNOWN ·Phase: NA
-
Effect of Weight Loss and Exercise on Liver and Muscle Fat in Obese Elderly
NCT00779207 ·Status: COMPLETED ·Phase: PHASE3
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
Effect of Diet Composition on Liver Fat and Glucose Metabolism
NCT00930371 ·Status: COMPLETED ·Phase: NA
-
Alternate Day Fasting, Exercise, and NAFLD
NCT04004403 ·Status: COMPLETED ·Phase: NA
-
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
NCT05332613 ·Status: RECRUITING ·Phase: NA
-
Impact of Time-restricted Feeding in NAFLD
NCT05220956 ·Status: RECRUITING ·Phase: NA
-
Impact of Exercise Intervention for Patients With Non-alcoholic Fatty Liver Disease
NCT04463667 ·Status: UNKNOWN ·Phase: NA
-
Clinical Study on the Treatment of MAFLD With Ganzhixiao Capsules
NCT06848907 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Role of New Adipokines and Hepatokines in Prediction of Patients With Metabolic Syndrome or NAFLD
NCT02285218 ·Status: UNKNOWN
-
Effect of Modified Time-restricted Feeding in Preventing Progression of Non-Alcoholic Fatty Liver Disease (NAFLD).
NCT03848390 ·Status: UNKNOWN ·Phase: NA
-
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00983463 ·Status: ENROLLING_BY_INVITATION